Award notice
Furosemide Tablets
SPE2D221R0110
Defense Logistics Agency, DLA Troop Support. Pharmaceutical Preparation Manufacturing.
Awarded
$16,701,923.95 on the award notice, December 8, 2021, contract SPE2D222D0140
Get the next one like this from Defense Logistics Agency by email, the day it is posted.Find my opportunities
This one was awarded in 2025
9 like it are open now in pharmaceutical preparation manufacturing
- FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052
Department of Veterans Affairs, 250-Network Contract Office 10
Sources soughtNAICS 325412Anywhere in the US36C25027Q0052Closes in 2 daysNov 3 - Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes in 2 daysNov 3 - LIDOCAINE 5% PATCHES-REQUEST FOR INFORMATION
Department of Veterans Affairs, National Cmop Office
Sources soughtNAICS 325412Anywhere in the US36C77027Q0010Closes in 2 daysNov 3
Description
As published on SAM.gov.
SPE2D2-22-D-0140 P00008 to exercise Option Year 4 effective December 08, 2025 through December 07, 2026.
SPE2D2-22-D-0140 P00007 is modified in accordance with DoD Class Deviation 2025-O0003.
SPE2D2-22-D-0140 P00006 to exercise Option Year 3 effective December 08, 2024 through December 07, 2025.
SPE2D2-22-D-0140 P00005 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation.
SPE2D2-22-D-0140 P00004 to exercise Option Year 2 effective December 08, 2023 through December 07, 2024.
SPE2D2-22-D-0140 P00003 to incorporate Drug Supply Chain Act (DSCA) language into solicitation for subject contract.
SPE2D2-22-D-0140 P00002 to Incorporate FAR 52.204-27 Prohibituion on a Bytedance Covered Application (June 2023) into contract.
Invocation of Option Year 1 Modification P00001 SPE2D2-22-D-0140
Contract Award for Furosemide Tablets SPE2D222D0140
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- Signed Furosemide SPE2D222D0140.pdf1.3 MB, December 8, 2021
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Avkare LLC
- UEI
- SFPGXE6XPS93
- CAGE
- 4QGW8
- Vendor location
- Pulaski, TN
- Contract
- SPE2D222D0140
- Obligated
- $0.00, potential $16,701,924
- Actions
- 4 between May 21, 2024 and November 25, 2025
- Competition
- Full and Open Competition, 2 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- 4610084131!manufacture/Distributor BR-PH
- Match
- award number SPE2D222D0140 equals the contract number; same awarding office SPE2D2 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
November 22, 2024
Award notice
Awarded to AvKARE, LLC Pulaski for $16,701,924. SAM.gov, notice e9f8ab2fad33491a9135d2dd7ef72813
November 25, 2025
Award notice
Awarded to AvKARE, LLC for $16,701,924. SAM.gov, notice 6193c84fe0de4750843eeca7032d6619
7 revisions on SAM
- November 25, 2025: publish, award notice
- November 22, 2024: publish, award notice
- November 24, 2023: publish, award notice
- August 7, 2023: publish, award notice
- November 10, 2022: publish, award notice
- December 8, 2021: publish, award notice
- July 30, 2021: publish, solicitation
Points of contact
- Kyle Lewickikyle.lewicki@dla.mil4457370977
- Jason WrayJason.wray@dla.mil4457376304